Tonix Pharmaceuticals Holding (TNXP) Deferred Taxes (2011 - 2016)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Deferred Taxes came in at -$9000.0 in Q1 2016, down 350.0% year-on-year from $3600.0 in Q2 2015, and down 120.0% quarter-over-quarter from $45000.0 in Q4 2015.
Tonix Pharmaceuticals Holding (TNXP) Deferred Taxes (2011 - 2016) Analysis & Trends
Tonix Pharmaceuticals Holding's Deferred Taxes history runs 6 years deep, the most recent figure standing at -$9000.0 for Q1 2016.
- On a quarterly basis, Deferred Taxes fell 350.0% year-over-year to -$9000.0 in Q1 2016; TTM through Mar 2016 was $47000.0, a 14.55% decrease from a year earlier, with the FY2015 full-year figure at $54000.0, down 1.82% from the prior year.
- Deferred Taxes declined to -$9000.0 in Q1 2016 per TNXP's latest filing, from $45000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $47000.0 in Q3 2014 and bottomed at -$9000.0 in Q1 2016.
- The 5-year median for Deferred Taxes is -$1000.0 (2013), against an average of $5294.1.
- Across the five-year window, Deferred Taxes surged 4800.0% in 2014 and tumbled 350.0% in 2016, its largest moves.
- Year by year, Deferred Taxes stood at -$1460.0 in 2012, then tumbled by 105.48% to -$3000.0 in 2013, then jumped by 400.0% to $9000.0 in 2014, then jumped by 400.0% to $45000.0 in 2015, then sank by 120.0% to -$9000.0 in 2016.
- Per Business Quant, the three latest TNXP Deferred Taxes figures stand at -$9000.0 (Q1 2016), $45000.0 (Q4 2015), and $12000.0 (Q3 2015).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Tonix Pharmaceuticals Holding | 140.53 Mn | 140.53 Mn | 5.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | -9,000.00 |
| Dec 31, 2015 | 45,000.00 |
| Sep 30, 2015 | 12,000.00 |
| Jun 30, 2015 | -1,000.00 |
| Mar 31, 2015 | -2,000.00 |
| Dec 31, 2014 | 9,000.00 |
| Sep 30, 2014 | 47,000.00 |
| Jun 30, 2014 | 1,000.00 |
| Mar 31, 2014 | -2,000.00 |
| Dec 31, 2013 | -3,000.00 |
| Sep 30, 2013 | -1,000.00 |
| Jun 30, 2013 | -2,000.00 |
| Mar 31, 2013 | -1,000.00 |
| Dec 31, 2012 | -1,460.00 |
| Sep 30, 2012 | -513.00 |
| Jun 30, 2012 | -514.00 |
| Mar 31, 2012 | -513.00 |
| Dec 31, 2011 | -514.00 |
| Sep 30, 2011 | 334.00 |
| Jun 30, 2011 | 334.00 |